[Therapeutic milestones in tumor therapy]

Area of Science:

• Oncology and Cancer Research
• Molecular Biology
• Translational Medicine

Context:

• The 20th century saw major advancements in traditional cancer therapies including surgery, radiation oncology, and medical oncology.
• Key milestones include identifying prostate cancer as hormone-sensitive and developing curative chemotherapy for hematological and testicular cancers.
• Adjuvant and preoperative chemotherapy have improved outcomes for breast and lung cancers, respectively.

Purpose:

• To review the historical advancements and current state of cancer treatment.
• To highlight the impact of molecular and cellular understanding on cancer therapy development.
• To showcase the clinical relevance of novel research in cancer treatment.

Summary:

• Cancer therapy has evolved significantly, driven by surgical, radiological, and chemotherapeutic interventions.
• Hormone sensitivity in prostate cancer and curative chemotherapy regimens represent major treatment successes.
• Advances in understanding cancer's molecular basis have led to targeted therapies like monoclonal antibodies, vaccines, and gene therapy.
• Preoperative chemotherapy is increasingly important for specific cancers like non-small cell lung cancer.

Impact:

• Improved patient prognoses and survival rates across various cancer types.
• Development of targeted therapies with potentially fewer side effects.
• Established a foundation for future personalized cancer medicine through basic and translational research.